| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |